# Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects

> **NCT03304548** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 10 (actual)

## Conditions studied

- Hypertension, Pulmonary

## Interventions

- **OTHER:** Telephone concept elicitation interview

## Key facts

- **NCT ID:** NCT03304548
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-22
- **Primary completion:** 2018-04-10
- **Final completion:** 2018-04-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03304548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03304548, "Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03304548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*